Effect of 12 months of recombinant human growth hormone replacement therapy on insulin sensitivity in GH-deficient adults as determined by different methods

Journal of Postgraduate Medicine

Volumn 48, Issue 4, 2002, Pages 260-265

  Micic, Dragan ^a   Cvijovic, G ^a   Doknic, M ^a   Kendereski, A ^a   Popovic, V ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

GH deficient adults; Insulin sensitivity; rhGH treatment

Indexed keywords

C PEPTIDE; GLUCOSE; HUMAN GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEVOTHYROXINE; MONOCOMPONENT INSULIN; TESTOSTERONE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METHODOLOGY; ORAL GLUCOSE TOLERANCE TEST; SIDE EFFECT; STATISTICAL ANALYSIS; WILCOXON SIGNED RANKS TEST;

ADULT; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; MALE; RADIOIMMUNOASSAY;

EID: 0036820444     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fowelin J, Attvall S, Lager I, Bengtsson BA. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metab Clin Exp 1993; 42:1443-47.
2. Rosenfalck AM, Maghsoudi S, Fisker S, Jorgensen JOL, Christiansen JS, Hilsted J et al. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rh-GH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness and body composition in GH-deficient adults. J Clin Endocrinol Metab 2000; 85:4173-81.
3. Rosenfalck AM, Fisker S, Hilsted J, Dinesen B, Volund A, Jorgensen JOL et al. The effect of the deterioration of insulin sensitivity on beta cell function in growth hormone deficient adults following four month growth hormone replacement therapy. Growth Horm IGF Res 1999; 9:96-105.
4. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB et al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-months placebo controlled cross over study. Clin Endocrinol (Oxf) 1992; 36:45-52.
5. Al-Shoumer KAS, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W et al. Effects of four year treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin Endocrinol (Oxf) 1998; 48:795-802.
6. DeFronzo RA, Tobin JD, Andres R. Glucose clamp tehnique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-23.
7. Radziuk J. Insulin sensitivity and its measurements: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85:4426-33.
8. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calulation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 1993; 42:250-6.
9. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivityin humans. J Clin Endocrinol Metab 2000; 85:2402-10.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9.
11. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986; 23:113-22.
12. Beshyah SA, Henderson A, Niththyananthan R, Skinner E, Anyaoku V, Richmond W et al. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 1995; 80:356-63.
13. Jeffcoate W. Can growth hormone therapy cause diabetes? Lancet 2000; 355:589-90.
14. Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 2000; 355:610-13.
15. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340:1188-92.
16. Johansson J-O, Fowelin J, Landin K, Lager I, Bengtsson B-A. Growth hormone - deficient adults are insulin resistant. Metabolism 1995; 44:1126-9.
17. Christopher M, Hew FL, Oakley M, Rantzau C, Alford F. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone - deficient adults persist after 24 months of recombinant human growth hormone therapy. J Clin Endocrinol Metab 1998; 83:1668-81.
18. Weaver JU, Monson JP, Noonan K, John WG, Edwards A, Evans KA et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 1995; 80:153-9.
19. Gibney J, Wallace JD, Spinks T. Schnorr L, Ranicar A, Cuneo RC et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH deficient patients. J Clin Endocrinol Metab 1999; 84:2596-602.
20. Chrisoulidou A, Beshyah SA, Rutherford O, Spinks TJ, Mayet J. Kyd P et al. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. J Clin Endocrinol Metab 2000; 85:3762-9.
21. Jorgensen JOL, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;1221-5.